-
AI player twoXAR teams up with 1ST Biotherapeutics on glioblastoma
fiercebiotech
January 04, 2019
TwoXAR and South Korea’s 1ST Biotherapeutics are joining forces to discover and develop new treatments for glioblastoma, the most aggressive kind of brain cancer.....
-
Merck KGaA taps Cyclica for AI-based screening of protein-drug interactions
fiercebiotech
December 28, 2018
Merck KGaA has licensed a cloud-based artificial intelligence proteome screening platform from the Toronto-based Cyclica.The yearlong agreement will allow the German biotech to evaluate the mechanisms of action and...
-
Owkin launches global patient data sharing network for training AIs
fiercebiotech
December 26, 2018
Owkin has unveiled what it describes as the world’s largest network for artificial intelligence-based medical research, encompassing over 40 institutions from the U.S. and France.....
-
NVIDIA partners with Scripps to develop digital health AI
pharmaphorum
December 20, 2018
The Scripps Research Translational Institute is partnering with graphics firm NVIDIA to develop AI and deep learning best practices, tools and infrastructure to develop AI applications using genomic and digital health sensor data
-
Cambridge Heartwear launches first AI-Driven Wearable 'Heartsense monitor'
biospectrumasia
December 17, 2018
The company is also providing Heartsense monitors to communities in India and Africa to help prevent heart disease and stroke amongst patients. The device will be available on the market in early 2019.
-
UK government backs five new AI health projects
pharmaphorum
December 13, 2018
The UK government has backed five new centres for artificial intelligence (AI) in health, focusing on areas including pathology, radiology and imaging.
-
Clark Health Communications forms alliance with Egg
pharmaphorum
December 13, 2018
London-based consultancy Clark Health Communications is partnering with digital solutions agency Egg in a collaboration that will see them offer their services to each other’s clients.
-
Merck KGaA links with AI firm to iron out side-effects during R&D
pharmaphorum
December 11, 2018
Germany’s Merck KGaA has begun a licensing agreement with Canadian pharma R&D company Cyclica using artificial intelligence (AI) to uncover new drug targets and predict any side effects.
-
Merck partners with Cyclica for AI-based screening of drug targets
pharmaceutical-technology
December 11, 2018
Merck has signed an agreement to licence Canadian Cyclica’s cloud-based in-silico proteome screening platform called Ligand Express to support its research efforts......
-
AI app decreases symptoms of COPD, study finds
pharmatimes
December 11, 2018
A new clinical study has found that Kaia Health’s artificial intelligence app successfully decreases symptoms of Chronic Obstructive Pulmonary Disease (COPD).